1 Market Overview

1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing

1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Type

1.2.1 Overview: Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type in 2021

1.2.3 Plasmid DNA

1.2.4 Viral Vectors

1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market by Application

1.3.1 Overview: Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Cancers

1.3.3 Inherited Disorders

1.3.4 Viral Infections

1.3.5 Others

1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Size & Forecast

1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast by Region

1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region, (2017-2022)

1.5.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2017-2028)

1.5.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2017-2028)

1.5.6 South America Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Viral Vectors and Plasmid DNA Manufacturing Market Drivers

1.6.2 Viral Vectors and Plasmid DNA Manufacturing Market Restraints

1.6.3 Viral Vectors and Plasmid DNA Manufacturing Trends Analysis

2 Company Profiles

2.1 BioReliance

2.1.1 BioReliance Details

2.1.2 BioReliance Major Business

2.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.1.4 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 BioReliance Recent Developments and Future Plans

2.2 Cobra Biologics

2.2.1 Cobra Biologics Details

2.2.2 Cobra Biologics Major Business

2.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.2.4 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Cobra Biologics Recent Developments and Future Plans

2.3 Oxford BioMedica

2.3.1 Oxford BioMedica Details

2.3.2 Oxford BioMedica Major Business

2.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.3.4 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Oxford BioMedica Recent Developments and Future Plans

2.4 UniQure

2.4.1 UniQure Details

2.4.2 UniQure Major Business

2.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.4.4 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 UniQure Recent Developments and Future Plans

2.5 FinVector

2.5.1 FinVector Details

2.5.2 FinVector Major Business

2.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.5.4 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 FinVector Recent Developments and Future Plans

2.6 MolMed

2.6.1 MolMed Details

2.6.2 MolMed Major Business

2.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.6.4 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 MolMed Recent Developments and Future Plans

2.7 MassBiologics

2.7.1 MassBiologics Details

2.7.2 MassBiologics Major Business

2.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.7.4 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 MassBiologics Recent Developments and Future Plans

2.8 Richter-Helm

2.8.1 Richter-Helm Details

2.8.2 Richter-Helm Major Business

2.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.8.4 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Richter-Helm Recent Developments and Future Plans

2.9 FUJIFILM Diosynth Biotechnologies

2.9.1 FUJIFILM Diosynth Biotechnologies Details

2.9.2 FUJIFILM Diosynth Biotechnologies Major Business

2.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

2.10 Lonza

2.10.1 Lonza Details

2.10.2 Lonza Major Business

2.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.10.4 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Lonza Recent Developments and Future Plans

2.11 Aldevron

2.11.1 Aldevron Details

2.11.2 Aldevron Major Business

2.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.11.4 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Aldevron Recent Developments and Future Plans

2.12 Eurogentec

2.12.1 Eurogentec Details

2.12.2 Eurogentec Major Business

2.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.12.4 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Eurogentec Recent Developments and Future Plans

2.13 Cell and Gene Therapy Catapult

2.13.1 Cell and Gene Therapy Catapult Details

2.13.2 Cell and Gene Therapy Catapult Major Business

2.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.13.4 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans

2.14 Biovian

2.14.1 Biovian Details

2.14.2 Biovian Major Business

2.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.14.4 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Biovian Recent Developments and Future Plans

2.15 Thermo Fisher Scientific (Brammer Bio)

2.15.1 Thermo Fisher Scientific (Brammer Bio) Details

2.15.2 Thermo Fisher Scientific (Brammer Bio) Major Business

2.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments and Future Plans

2.16 VGXI

2.16.1 VGXI Details

2.16.2 VGXI Major Business

2.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.16.4 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 VGXI Recent Developments and Future Plans

2.17 PlasmidFactory

2.17.1 PlasmidFactory Details

2.17.2 PlasmidFactory Major Business

2.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

2.17.4 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 PlasmidFactory Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Viral Vectors and Plasmid DNA Manufacturing Players Market Share in 2021

3.2.2 Top 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Viral Vectors and Plasmid DNA Manufacturing Players Head Office, Products and Services Provided

3.4 Viral Vectors and Plasmid DNA Manufacturing Mergers & Acquisitions

3.5 Viral Vectors and Plasmid DNA Manufacturing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2017-2022)

4.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2017-2022)

5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2028)

6.2 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2028)

6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

6.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2028)

6.3.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

6.3.3 Canada Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

6.3.4 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2028)

7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2028)

7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

7.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2028)

7.3.2 Germany Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

7.3.3 France Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

7.3.5 Russia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

7.3.6 Italy Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2028)

8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2028)

8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region

8.3.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Region (2017-2028)

8.3.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

8.3.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

8.3.4 South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

8.3.5 India Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

8.3.7 Australia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2028)

9.2 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2028)

9.3 South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

9.3.1 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2028)

9.3.2 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

9.3.3 Argentina Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2028)

10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2028)

10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

10.3.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2028)

10.3.2 Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

10.3.4 UAE Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) by Region (2017-2022)

Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region (2023-2028)

Table 6. BioReliance Corporate Information, Head Office, and Major Competitors

Table 7. BioReliance Major Business

Table 8. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 9. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Cobra Biologics Corporate Information, Head Office, and Major Competitors

Table 11. Cobra Biologics Major Business

Table 12. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 13. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Oxford BioMedica Corporate Information, Head Office, and Major Competitors

Table 15. Oxford BioMedica Major Business

Table 16. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 17. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. UniQure Corporate Information, Head Office, and Major Competitors

Table 19. UniQure Major Business

Table 20. UniQure Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 21. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. FinVector Corporate Information, Head Office, and Major Competitors

Table 23. FinVector Major Business

Table 24. FinVector Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 25. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. MolMed Corporate Information, Head Office, and Major Competitors

Table 27. MolMed Major Business

Table 28. MolMed Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 29. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. MassBiologics Corporate Information, Head Office, and Major Competitors

Table 31. MassBiologics Major Business

Table 32. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 33. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Richter-Helm Corporate Information, Head Office, and Major Competitors

Table 35. Richter-Helm Major Business

Table 36. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 37. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. FUJIFILM Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 39. FUJIFILM Diosynth Biotechnologies Major Business

Table 40. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 41. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Lonza Corporate Information, Head Office, and Major Competitors

Table 43. Lonza Major Business

Table 44. Lonza Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 45. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Aldevron Corporate Information, Head Office, and Major Competitors

Table 47. Aldevron Major Business

Table 48. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 49. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Eurogentec Corporate Information, Head Office, and Major Competitors

Table 51. Eurogentec Major Business

Table 52. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 53. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Cell and Gene Therapy Catapult Corporate Information, Head Office, and Major Competitors

Table 55. Cell and Gene Therapy Catapult Major Business

Table 56. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 57. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Biovian Corporate Information, Head Office, and Major Competitors

Table 59. Biovian Major Business

Table 60. Biovian Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 61. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Thermo Fisher Scientific (Brammer Bio) Corporate Information, Head Office, and Major Competitors

Table 63. Thermo Fisher Scientific (Brammer Bio) Major Business

Table 64. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 65. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. VGXI Corporate Information, Head Office, and Major Competitors

Table 67. VGXI Major Business

Table 68. VGXI Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 69. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. PlasmidFactory Corporate Information, Head Office, and Major Competitors

Table 71. PlasmidFactory Major Business

Table 72. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product and Solutions

Table 73. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Viral Vectors and Plasmid DNA Manufacturing Players Head Office, Products and Services Provided

Table 78. Viral Vectors and Plasmid DNA Manufacturing Mergers & Acquisitions in the Past Five Years

Table 79. Viral Vectors and Plasmid DNA Manufacturing New Entrants and Expansion Plans

Table 80. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) by Type (2017-2022)

Table 81. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2017-2022)

Table 82. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2023-2028)

Table 83. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2022)

Table 84. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2023-2028)

Table 85. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Viral Vectors and Plasmid DNA Manufacturing Picture

Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type in 2021

Figure 3. Plasmid DNA

Figure 4. Viral Vectors

Figure 5. Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application in 2021

Figure 6. Cancers Picture

Figure 7. Inherited Disorders Picture

Figure 8. Viral Infections Picture

Figure 9. Others Picture

Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region (2017-2028)

Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region in 2021

Figure 14. North America Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Viral Vectors and Plasmid DNA Manufacturing Market Drivers

Figure 20. Viral Vectors and Plasmid DNA Manufacturing Market Restraints

Figure 21. Viral Vectors and Plasmid DNA Manufacturing Market Trends

Figure 22. BioReliance Recent Developments and Future Plans

Figure 23. Cobra Biologics Recent Developments and Future Plans

Figure 24. Oxford BioMedica Recent Developments and Future Plans

Figure 25. UniQure Recent Developments and Future Plans

Figure 26. FinVector Recent Developments and Future Plans

Figure 27. MolMed Recent Developments and Future Plans

Figure 28. MassBiologics Recent Developments and Future Plans

Figure 29. Richter-Helm Recent Developments and Future Plans

Figure 30. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

Figure 31. Lonza Recent Developments and Future Plans

Figure 32. Aldevron Recent Developments and Future Plans

Figure 33. Eurogentec Recent Developments and Future Plans

Figure 34. Cell and Gene Therapy Catapult Recent Developments and Future Plans

Figure 35. Biovian Recent Developments and Future Plans

Figure 36. Thermo Fisher Scientific (Brammer Bio) Recent Developments and Future Plans

Figure 37. VGXI Recent Developments and Future Plans

Figure 38. PlasmidFactory Recent Developments and Future Plans

Figure 39. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players in 2021

Figure 40. Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 41. Global Top 3 Players Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in 2021

Figure 42. Global Top 10 Players Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in 2021

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 44. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type in 2021

Figure 45. Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Type (2023-2028)

Figure 46. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application in 2021

Figure 47. Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Application (2023-2028)

Figure 48. North America Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2017-2028)

Figure 49. North America Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2017-2028)

Figure 50. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Country (2017-2028)

Figure 51. United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Canada Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Mexico Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Europe Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2017-2028)

Figure 55. Europe Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2017-2028)

Figure 56. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Country (2017-2028)

Figure 57. Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. United Kingdom Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2017-2028)

Figure 63. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2017-2028)

Figure 64. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region (2017-2028)

Figure 65. China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South Korea Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Australia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South America Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2017-2028)

Figure 72. South America Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2017-2028)

Figure 73. South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Country (2017-2028)

Figure 74. Brazil Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Argentina Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Country (2017-2028)

Figure 79. Turkey Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. UAE Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source